Two Faces of Arbutine in Hepatocelluler Carcinoma (HepG2) Cells: Anticarcinogenic Effect in LD50 Dose and Protective Effect Against Cisplatin Toxication Through its Antioxidant and Anti-inflammatory Activity in LD0 Dose
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI